Flu drug maker BioCryst Pharmaceuticals Inc. said Wednesday it elected Charles Sanders to its board of directors. Sanders worked for five years as CEO of Glaxo Inc., which is now part of GlaxoSmithKline PLC, and was chairman of the Glaxo board for three…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




BioCryst Pharmaceuticals – GlaxoSmithKline – Pharmaceutical industry – Bristol-Myers Squibb – Board of directors

BioCryst elects ex-Glaxo and Squibb exec to board